


Ask a doctor about a prescription for LETROZOLE SANDOZ 2.5 mg FILM-COATED TABLETS
Package Leaflet: Information for the Patient
Letrozol Sandoz 2.5 mg film-coated tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is Letrozol Sandoz and how does it work
Letrozol Sandoz contains the active substance letrozole. It belongs to a group of medicines called aromatase inhibitors. It is a hormonal (or "endocrine") treatment for breast cancer. The growth of breast cancer is often stimulated by estrogens, which are female sex hormones. Letrozol Sandoz reduces the amount of estrogen by blocking an enzyme (aromatase) involved in estrogen production and can therefore block the growth of breast cancers that need estrogens to grow. As a result, tumor cells grow more slowly or stop growing and/or spreading to other parts of the body.
What is Letrozol Sandoz used for
Letrozole is used to treat breast cancer in women who have gone through the menopause, i.e. the cessation of menstrual periods.
It is used to prevent breast cancer from coming back. It can be used as the first treatment before breast cancer surgery, in case surgery is not immediately possible, or it can be used as the first treatment after breast cancer surgery, or after five years of treatment with tamoxifen. Letrozol Sandoz is also used to prevent the breast tumor from spreading to other parts of the body in patients with advanced breast cancer.
If you have any questions about how Letrozol Sandoz works or why you have been prescribed this medicine, ask your doctor.
Follow carefully all instructions given to you by your doctor. They may differ from the general information contained in this leaflet.
Do not take Letrozol Sandoz
If any of these conditions apply to you, do not take this medicine and inform your doctor.
Warnings and precautions
Talk to your doctor or pharmacist before starting Letrozol Sandoz
If any of these conditions apply to you, tell your doctor.Your doctor will take this into account during your treatment with Letrozol Sandoz.
Letrozole may cause tendon inflammation or tendon damage (see section 4). If you experience any signs of pain or inflammation of the tendons, rest the affected area and contact your doctor.
Children and adolescents (under 18 years)
Children and adolescents should not use this medicine.
Elderly patients (65 years and over)
People 65 years and over can use this medicine at the same dose as for adults.
Taking Letrozol Sandoz with other medicines
Tell your doctor or pharmacist that you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.
Pregnancy, breast-feeding, and fertility
Driving and using machines
If you feel dizzy, tired, sleepy, or unwell, do not drive or operate tools or machines until you feel better.
Letrozol Sandoz contains lactose
Letrozol Sandoz contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Letrozol Sandoz contains less than 23 mmol of sodium (1 mmol) per film-coated tablet; this is essentially "sodium-free".
Follow exactly the instructions of administration of this medicine given to you by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The usual dose is one Letrozol Sandoz tablet once a day. If you take Letrozol Sandoz at the same time every day, it will help you remember when to take the tablet.
The tablet can be taken with or without food and should be swallowed whole with a glass of water or other liquid.
How long to take Letrozol Sandoz
Keep taking Letrozol Sandoz every day for as long as your doctor tells you to. You may need to take it for months or even years. If you have any doubts about how long to take Letrozol Sandoz, ask your doctor.
Monitoring of treatment with Letrozol Sandoz
You should only take this medicine under strict medical supervision. Your doctor will regularly check your condition to ensure that the treatment has the desired effect.
Letrozol Sandoz may cause a decrease in bone density or bone loss (osteoporosis) due to the decrease in estrogen in the body. Your doctor may decide to perform bone density measurements (a way to monitor osteoporosis) before, during, and after treatment.
If you take more Letrozol Sandoz than you should
If you have taken too many Letrozol Sandoz tablets, or if someone else has taken your tablets, contact your doctor or go to the hospital immediately. Show them the pack of tablets. You may need medical treatment. If you have taken more Letrozol Sandoz than you should, contact your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.
If you forget to take Letrozol Sandoz
If you stop taking Letrozol Sandoz
Do not stop taking Letrozol Sandoz unless your doctor tells you to. See also the section "How long to take Letrozol Sandoz".
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most side effects are mild to moderate and usually disappear after a few days or weeks of treatment.
Some of these side effects, such as hot flashes, hair loss, or vaginal bleeding, may be due to the lack of estrogen.
Do not be alarmed by this list of possible side effects. You may not get any of them.
Some side effects can be serious:
Uncommon side effects(may affect up to 1 in 100 people):
-
Rare side effects(may affect up to 1 in 1,000 people)
If you experience any of these, tell your doctor immediately.
You should also tell your doctor immediatelyif you experience any of the following symptomsduring treatment with Letrozol Sandoz:
Some side effects are very common(may affect more than 1 in 10 people:
If any of these effects bother you seriously, talk to your doctor.
Some side effects are common(may affect up to 1 in 10 people:
If any of these effects bother you seriously, talk to your doctor.
Other side effects are uncommon(may affect up to 1 in 100 people:
Other side effects are rare(may affect up to 1 in 1,000 people):
Side effects with unknown frequency(cannot be estimated from available data):
If any of these bother you seriously, talk to your doctor.
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Composition of Letrozol Sandoz
Appearance of Letrozol Sandoz and contents of the pack
Letrozol Sandoz 2.5 mg is presented as yellow, round, and biconvex film-coated tablets, marked with L9OO on one side and 2.5 on the other.
Letrozol Sandoz is presented in PVC-Aluminum blisters of 10, 28, 30, 50, 60, 84, 90, 98, or 100 tablets per box.
Not all pack sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Synthon Hispania S.L.
Castelló 1
Polígono Las Salinas
08830 Sant Boi de Llobregat
Spain
or
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Barleben
Germany
or
Synthon BV
Microweg 22
6545 CM Nijmegen
Netherlands
or
Rottendorf Pharma GmbH
Ostenfelder strasse 51-61
59320 Ennigerloht
Germany
or
Lek Pharmaceuticals d.d.
Verovskova 57
1526 Ljubljana
Slovenia
This medicine is authorized in the Member States of the European Economic Area under the following names:
Slovakia: Letrozol Sandoz 2,5 mg filmom obalené tablety
Czech Republic: Letrozol Sandoz 2,5 mg
Hungary: Letrozol Sandoz 2,5 mg filmtableta
Netherlands: Letrozol Sandoz 2,5 mg filmomhulde tabletten
Date of last revision of this leaflet:November 2019.
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of LETROZOLE SANDOZ 2.5 mg FILM-COATED TABLETS in November, 2025 is around 92.1 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for LETROZOLE SANDOZ 2.5 mg FILM-COATED TABLETS – subject to medical assessment and local rules.